阿托伐他汀对血脂正常高血压患者ABI及HCY的影响被引量：2

Influence of atorvastatin on ABI and HCY in essential hypertensives with normal lipidemia

下载PDF

导出

摘要目的观察阿托伐他汀对血脂正常的原发性高血压患者ankle-brachial index(ABI)及homocysteine(HCY)影响。方法血脂正常的原发性高血压患者130例随机分为对照组(n=63)和治疗组(n=67,阿托伐他汀20mg,每晚1次),疗程均为6个月。入选前所有患者经服用降压药物后血压控制在140/90mm Hg以下至少4周,观察ABI、HCY在治疗前后的变化。结果治疗6月末时,阿托伐他汀组治疗6月前后,ABI、HCY均有统计学差异(均P<0.05)。对照组治疗前后ABI、HCY的差异均无统计学意义(P>0.05)。结论阿托伐他汀可升高ABI,降低HCY,改善原发性高血压患者发生心脑血管疾病并发症的风险。 Objective To observe the effect of atorvastatin on the serum homocysteine and ankle brachial index（ABI） in essential hypertensives with normal lipidemia. Methods One hundred and thirty essential hypertensives with normal lipidemia regularly taking anti-hypertension drugs were randomly divided into control group（n=63） and atorvastatin group（n=67） and treated for 6months. ABI and HCY were measured before and after treatment. Results No change of all measurements in control group was found after treatment. In atorvastatin group,however,ABI is increased,HCY is decreased（P〈0.05）. Conclusions Atorvastatin can rise ABI,reduce HCY,improve risk of complication in hypertensives.

作者孙国锋陈图刚谭维羚马战清钟志英

机构地区南昌大学第四附属医院心内科

出处《江西医药》 CAS 2015年第10期998-1001,共4页 Jiangxi Medical Journal

关键词阿托伐他汀高血压同型半胱氨酸踝臂指数 Atorvastatin Hypertension Homocysteine Ankle brachial index

分类号 R544.1 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献16

1Tayama J,Munakata M,Yoshinaga K,et al. Higher plasma homo- cysteine concentrations associated with more advanced systemic ar- terial stiffness and greater blood pressure response to stress in hy- pertensive patients[J]. Hypertens Res, 2006,9 (6) : 403-409.
2Bhatt DL,Wilson PW,D Agostino R Sr,et al. REACH Registry In- vestigators. One year cardiovascular event rates in outpatients with atherothrombosis[J]. JAMA 2007 ;297(11) : 1197-206.
3Mkenna M ,Wolson S,Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality[J]. Atheroselero- sis 1991 ;87:119-28.
4Gallego P,Roldm V,Marln F,et al. Ankle brachial index as an in- dependent predictor of mortality in antieoagulated atrial fibrilla- tion [J]. European Journal of Clinical Investigation,2012,42(12): 1302-1308.
5Low-dose atorvastatin reduces ambulatory blood pressure in pa- tients with mild hypertension and hypereholesterolaemia:a double- blind,randomized,placebo-controlled study [J]. Journal of human Hypertension, 2012,10 : 577-84.
6Kanaki A, Sarafidis P, Georgianos P, et al. Effects of low-dose ator- vastatin on arterial stiffness and central aortic pressure augmenta- tion in patients with hypertension and bypercholesterolemia [J]. American journal of hypertension, 2013,5 : 608-16.
7Edita Ma?anauskien?;Albinas Naud?ianas. Comparison of Ankle- Brachial Index in Patients With and Without Atria/ Fibrillation[J]. Medicina (Kaunas), 2011 ;47(12) :641-5.
8Belch J],Topol EJ,Agnelli G,et al. Critical issues in peripheral arterial disease detection and management [J]. Arch Inter Med, 2003,163(8) : 884-92.
9Hirsch AT,Criqui MH,Treat-Jacobson D,et al. Peripheral arterial disease detection,awareness,and treatment in primary care[J]. JA- MA, 2001,286(11) : 1317-24.
10Drewes, vonne M ; Poortvliet, Rosalinde KE, et al. Homocysteinelevels and treatment effect in the PROspective Study of Pravastati in the Elderly at Risk[J]. Journal of the American Geriatrics Soci1 ety,2014,2:213-21.